Preferred Label : dioxoles;
Is substance : O;
Origin ID : D004149;
UMLS CUI : C0012505;
Allowable qualifiers
Currated CISMeF NLP mapping
Record concept(s)
Related MeSH Supplementary Concept(s)
- (3aR,8aR)-2,2-dimethyl-4,4,8,8-tetraphenyl-4,5,6,7,8,8a-hexahydro-3aH-1,3-dioxolo(4,5-e)(1,3)diazepin-6-one [MeSH Supplementary Concept]
- CX509 [MeSH Supplementary Concept]
- EAB 309 [MeSH Supplementary Concept]
- ET 637 [MeSH Supplementary Concept]
- J 2922 [MeSH Supplementary Concept]
- JTE 907 [MeSH Supplementary Concept]
- LL 15 [MeSH Supplementary Concept]
- S 38809 [MeSH Supplementary Concept]
- YCZ-18 [MeSH Supplementary Concept]
- apiole [MeSH Supplementary Concept]
- laetine [MeSH Supplementary Concept]
- sesamex [MeSH Supplementary Concept]
- sesamin [MeSH Supplementary Concept]
- yatein [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
https://www.ema.europa.eu/medicines/human/EPAR/Yondelis
2012
United Kingdom
English
French
syndication feed
orphan drug production
sarcoma
drug approval
treatment outcome
drug labeling
antineoplastic agents, alkylating
antineoplastic agents, alkylating
dioxoles
dioxoles
tetrahydroisoquinolines
tetrahydroisoquinolines
adult
drug interactions
pregnancy
infusions, intravenous
breast feeding
mutagens
drug evaluation, preclinical
trabectedin
dioxoles
tetrahydroisoquinolines
drug evaluation
package leaflet
summary of product characteristics
Trabectedin
Trabectedin
---